Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man
- PMID: 3553849
- DOI: 10.1016/0026-0495(87)90044-8
Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man
Abstract
Plasma concentrations of insulin, C-peptide, and proinsulin were measured in different vascular beds in order to determine renal, hepatic, and systemic kinetics of the endogenous peptides in the fasting condition. Nineteen nondiabetic subjects were studied, two were normal, nine had minor vascular disorders, four had cirrhosis without organic kidney disease, and four had organic kidney disease with moderately decreased glomerular filtration rate. In subjects without organic kidney disease the arteriorenal venous extraction ratios of insulin, C-peptide, and proinsulin were mean 0.27, 0.20, and 0.21, respectively (n = 14). These values were significantly reduced in kidneys with organic disease. Renal plasma clearance values of insulin, C-peptide, and proinsulin were mean 113, 87, and 90 mL/min, respectively (n = 6). Urinary clearances were substantially lower (0.8, 13, 3.5 mL/min, respectively), indicating that a significant degradation of these peptides also takes place in the normal kidney. In subjects without liver disease the estimated hepatic extraction ratio of insulin was mean 0.48, under the assumption that no C-peptide is removed by the liver. Endogenously released insulin was removed from plasma in kidney, liver, and elsewhere in the approximate proportion 10%:65%:25%, whereas, C-peptide was removed by one half in kidney and the other half elsewhere. The overall metabolic clearance rates of insulin and C-peptide were estimated to be 15 and 4.5 mL/min/kg, respectively. The results indicate that the kidney contributes substantially to removal of insulin, C-peptide, an proinsulin, mainly by degradation, less by urinary excretion.
Similar articles
-
Metabolism of proinsulin, insulin, and C-peptide in the rat.J Clin Invest. 1973 May;52(5):1113-21. doi: 10.1172/JCI107277. J Clin Invest. 1973. PMID: 4700486 Free PMC article.
-
Plasma levels of proinsulin, insulin and C-peptide in chronic renal, hepatic and muscular disorders.Jpn J Med. 1984 Feb;23(1):3-8. doi: 10.2169/internalmedicine1962.23.3. Jpn J Med. 1984. PMID: 6379242
-
The metabolism of proinsulin and insulin by the liver.J Clin Invest. 1972 Apr;51(4):912-21. doi: 10.1172/JCI106886. J Clin Invest. 1972. PMID: 5014618 Free PMC article.
-
C-peptide measurement: methods and clinical utility.Crit Rev Clin Lab Sci. 1984;19(4):297-352. doi: 10.3109/10408368409165766. Crit Rev Clin Lab Sci. 1984. PMID: 6373142 Review.
-
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations.Diabetes. 1984 May;33(5):486-94. doi: 10.2337/diab.33.5.486. Diabetes. 1984. PMID: 6373457 Review.
Cited by
-
Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals.Pharm Res. 2016 Dec;33(12):2920-2929. doi: 10.1007/s11095-016-2014-1. Epub 2016 Aug 15. Pharm Res. 2016. PMID: 27528391 Free PMC article.
-
Features, prevention and management of acute overdose due to antidiabetic drugs.Drug Saf. 1993 Sep;9(3):218-29. doi: 10.2165/00002018-199309030-00007. Drug Saf. 1993. PMID: 8240727 Review.
-
Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.Diabetologia. 1991 Jun;34(6):423-8. doi: 10.1007/BF00403181. Diabetologia. 1991. PMID: 1884901
-
Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population.J Pers Med. 2022 Jul 12;12(7):1131. doi: 10.3390/jpm12071131. J Pers Med. 2022. PMID: 35887628 Free PMC article.
-
Physiological effects and therapeutic potential of proinsulin C-peptide.Am J Physiol Endocrinol Metab. 2014 Dec 1;307(11):E955-68. doi: 10.1152/ajpendo.00130.2014. Epub 2014 Sep 23. Am J Physiol Endocrinol Metab. 2014. PMID: 25249503 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical